Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 133541 - 133560 out of 485545 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01EA02) dasatinib | DASATINIB MYLAN | 70MG, 70MG TBL FLM 60 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | VIATRISLIMITED,Dublin |
| Czech Republic | (L01EA02) dasatinib | DASATINIB TEVA | 70MG, 70MG TBL FLM 60X1 , BLJ | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V.,Haarlem |
| Czech Republic | (L01EA02) dasatinib | SPRYCEL | 70MG, 70MG TBL FLM 60 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbPharmaEEIG,Dublin |
| Czech Republic | (L01EA03) nilotinib | TASIGNA | 150MG, 150MG CPS DUR 112(4X28) I , BLI | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EA03) nilotinib | TASIGNA | 200MG, 200MG CPS DUR 112(4X28) I POUZDRO , BLI | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EA03) nilotinib | TASIGNA | 200MG, 200MG CPS DUR 112(4X28) I , BLI | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EA05) ponatinib | ICLUSIG | 15MG, 15MG TBL FLM 60 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid; Leukemia, Lymphoid | IncyteBiosciencesDistributionB.V.,Amsterdam |
| Czech Republic | (L01EB01) gefitinib | GEFITINIB ACCORD | 250MG, 250MG TBL FLM 30X1 , BLJ | Retail price with vat |
$0-0 |
$0-0 |
n/a | ACCORDHEALTHCAREPOLSKASp.zo.o.,Varšava |
| Czech Republic | (L01EB01) gefitinib | GEFITINIB ALVOGEN | 250MG, 250MG TBL FLM 30X1 , BLJ | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s.,Praha |
| Czech Republic | (L01EB01) gefitinib | GEFITINIB ZENTIVA | 250MG, 250MG TBL FLM 30X1 , BLJ | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s.,Praha |
| Czech Republic | (L01EB01) gefitinib | IRESSA | 250MG, 250MG TBL FLM 30X1 , BLJ | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB,Södertälje |
| Czech Republic | (L01EB01) gefitinib | IRESSA | 250MG, 250MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB,Södertälje |
| Czech Republic | (L01EB02) erlotinib | ERLOTINIB TEVA B. V. | 100MG, 100MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V.,Haarlem |
| Czech Republic | (L01EB02) erlotinib | ERLOTINIB VIPHARM | 100MG, 100MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | VipharmS.A.,OżarówMazowiecki |
| Czech Republic | (L01EB02) erlotinib | ERLOTINIB ZENTIVA | 100MG, 100MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s.,Praha |
| Czech Republic | (L01EB02) erlotinib | ERLOTINIB TEVA B. V. | 150MG, 150MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V.,Haarlem |
| Czech Republic | (L01EB02) erlotinib | ERLOTINIB VIPHARM | 150MG, 150MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | VipharmS.A.,OżarówMazowiecki |
| Czech Republic | (L01EB02) erlotinib | ERLOTINIB ZENTIVA | 150MG, 150MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s.,Praha |
| Czech Republic | (L01EB03) afatinib | GIOTRIF | 20MG, 20MG TBL FLM 28X1 , BLJ | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimInternationalGmbH,IngelheimamRhein |
| Czech Republic | (L01EB03) afatinib | GIOTRIF | 30MG, 30MG TBL FLM 28X1 , BLJ | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimInternationalGmbH,IngelheimamRhein |
Pages
